Merck & Co., Inc. (MRK)
126.49
+1.04
(+0.83%)
USD |
NYSE |
Jun 26, 09:39
Merck Gross Profit (TTM) : 48.11B for March 31, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | 48.11B |
| December 31, 2025 | 48.18B |
| September 30, 2025 | 48.44B |
| June 30, 2025 | 47.73B |
| March 31, 2025 | 47.64B |
| December 31, 2024 | 47.78B |
| September 30, 2024 | 45.93B |
| June 30, 2024 | 44.98B |
| March 31, 2024 | 43.76B |
| December 31, 2023 | 42.13B |
| September 30, 2023 | 40.86B |
| June 30, 2023 | 40.87B |
| March 31, 2023 | 40.87B |
| December 31, 2022 | 41.27B |
| September 30, 2022 | 42.74B |
| June 30, 2022 | 41.11B |
| March 31, 2022 | 38.74B |
| December 31, 2021 | 35.45B |
| September 30, 2021 | 31.26B |
| June 30, 2021 | 29.47B |
| March 31, 2021 | 27.78B |
| December 31, 2020 | 29.20B |
| September 30, 2020 | 31.51B |
| June 30, 2020 | 31.97B |
| March 31, 2020 | 33.72B |
| Date | Value |
|---|---|
| December 31, 2019 | 32.73B |
| September 30, 2019 | 32.20B |
| June 30, 2019 | 31.00B |
| March 31, 2019 | 29.58B |
| December 31, 2018 | 28.78B |
| September 30, 2018 | 28.16B |
| June 30, 2018 | 28.00B |
| March 31, 2018 | 27.87B |
| December 31, 2017 | 27.37B |
| September 30, 2017 | 27.04B |
| June 30, 2017 | 27.13B |
| March 31, 2017 | 26.70B |
| December 31, 2016 | 26.13B |
| September 30, 2016 | 25.66B |
| June 30, 2016 | 24.75B |
| March 31, 2016 | 24.34B |
| December 31, 2015 | 24.25B |
| September 30, 2015 | 24.28B |
| June 30, 2015 | 25.96B |
| March 31, 2015 | 26.88B |
| December 31, 2014 | 27.56B |
| September 30, 2014 | 28.38B |
| June 30, 2014 | 27.52B |
| March 31, 2014 | 27.81B |
| December 31, 2013 | 28.10B |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Johnson & Johnson | 65.49B |
| Eli Lilly & Co. | 59.84B |
| Pfizer Inc. | 41.25B |
| Bristol Myers Squibb Co. | 32.03B |
| Organon & Co. | 3.28B |